Passage Bio PASG

$ 0.51 -5.76%

Quarterly report 2024-Q3
added 11-13-2024

Passage Bio Financial Statements 2011-2024 | PASG

Annual Financial Statements Passage Bio

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	93.1 M	65.9 M	268 M	447 M	-	-	-	-	-	-	-	-	-
Shares	54.7 M	54.4 M	53.3 M	24 M	-	-	-	-	-	-	-	-	-
Historical Prices	1.7	1.21	5.03	18.7	-	-	-	-	-	-	-	-	-
Net Income	-102 M	-136 M	-185 M	-112 M	-45.6 M	-12.8 M	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-108 M	-138 M	-186 M	-113 M	-37.2 M	-	-	-	-	-	-	-	-
Interest Expense	6.33 M	2.27 M	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-105 M	-135 M	-184 M	-112 M	-27.9 M	-14.2 M	-	-	-	-	-	-	-
Operating Expenses	-	-	-	113 M	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	41.6 M	49.3 M	60.1 M	30.1 M	6.95 M	928 K	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Passage Bio

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	61.8 M	61.7 M	56.3 M	54.9 M	54.8 M	54.7 M	54.6 M	54.6 M	54.5 M	54.4 M	54.3 M	54.2 M	54 M	53.9 M	51.3 M	45.6 M	45.5 M	45.4 M	17.6 M	4.29 M	4.25 M	4.21 M	4.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-19.3 M	-16 M	-16.7 M	-	-27.1 M	-23.9 M	-34.3 M	-	-26.7 M	-39.5 M	-42.8 M	-	-46.9 M	-48.4 M	-38.9 M	-	-28.5 M	-27.2 M	-17.6 M	-	-11.4 M	-13.4 M	-7.67 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-20.7 M	-17.4 M	-18 M	-	-28.7 M	-25.4 M	-35.9 M	-	-27.5 M	-39.8 M	-42.8 M	-	-47.1 M	-48.5 M	-38.9 M	-	-28.6 M	-27.3 M	-17.9 M	-	-11.6 M	-7.77 M	-4.19 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	1.36 M	1.39 M	1.34 M	-	1.56 M	1.53 M	1.54 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-19.9 M	-16.6 M	-17.2 M	-	-27.7 M	-24.4 M	-34.9 M	-	-26.6 M	-38.9 M	-41.9 M	-	-46.2 M	-48.5 M	-38.7 M	-	-28.1 M	-27.1 M	-17.9 M	-	-11.6 M	-7.72 M	-4.18 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	7.25 M	6.51 M	6.52 M	-	8.18 M	8.06 M	19 M	-	10.7 M	13 M	15.1 M	-	15 M	15.4 M	12.5 M	-	7.79 M	7.4 M	4.8 M	-	1.21 M	968 K	1.15 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency